Meanwhile, in subjects without NAFLD or MAFLD, the risk of arterial stiffness tended to increase in the Hp (±) group compared to Hp (−), but statistical significance was not observed (OR 1.23, 95% CI 0.92–1.65, P = 0.170 and OR 1.16, 95% CI 0.91–1.48, P = 0.237, respectively). This evidence concerns the gene HP and metabolic dysfunction-associated steatotic liver disease.